First experience with the Hugo™ robot-assisted surgery system for endometriosis: A descriptive study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
First experience with the Hugo™ robot-assisted surgery system for endometriosis : A descriptive study. / Olsen, Rikke Groth; Hartwell, Dorthe; Dalsgaard, Torur; Madsen, Mette Elkjær; Bjerrum, Flemming; Konge, Lars; Røder, Andreas.
In: Acta Obstetricia et Gynecologica Scandinavica, Vol. 103, No. 2, 2024, p. 368-377.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - First experience with the Hugo™ robot-assisted surgery system for endometriosis
T2 - A descriptive study
AU - Olsen, Rikke Groth
AU - Hartwell, Dorthe
AU - Dalsgaard, Torur
AU - Madsen, Mette Elkjær
AU - Bjerrum, Flemming
AU - Konge, Lars
AU - Røder, Andreas
N1 - Publisher Copyright: © 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
PY - 2024
Y1 - 2024
N2 - Introduction: The Medtronic Hugo™ Robot-assisted Surgery (RAS) system was recently approved for clinical use. We explored the safety and feasibility of this system for endometriosis surgery. The primary outcome was safe case completion without major surgical complications (Clavien–Dindo grade ≤2) and no conversion to open surgery or laparoscopy. Material and methods: Surgeries for endometriosis performed at the Department of Gynecology, Rigshospitalet, on the Medtronic Hugo™ RAS system were included. Two experienced robotic surgeons performed all surgeries with their usual robotic team. The variables included were patient demographics, peri- and postoperative data, complications and 30-day readmission rate. We used the IDEAL framework 1/2a for surgical innovation in this descriptive study. Results: The first 12 patients were included. All cases were completed without intraoperative complications or conversion. Four patients experienced Clavien–Dindo grade 1 postoperative complications. No patients were re-admitted within 30 days. Median docking time (17 minutes), console time (87.5 minutes), blood loss (40 mL) and length of hospital stay (1 day) were acceptable compared with previous literature. Conclusions: In this pilot study, we found the Medtronic Hugo™ RAS system safe and feasible for robot-assisted surgery for endometriosis. The advent of new robotic systems is welcomed to accelerate the development of technology that will advance surgical care for patients across the globe.
AB - Introduction: The Medtronic Hugo™ Robot-assisted Surgery (RAS) system was recently approved for clinical use. We explored the safety and feasibility of this system for endometriosis surgery. The primary outcome was safe case completion without major surgical complications (Clavien–Dindo grade ≤2) and no conversion to open surgery or laparoscopy. Material and methods: Surgeries for endometriosis performed at the Department of Gynecology, Rigshospitalet, on the Medtronic Hugo™ RAS system were included. Two experienced robotic surgeons performed all surgeries with their usual robotic team. The variables included were patient demographics, peri- and postoperative data, complications and 30-day readmission rate. We used the IDEAL framework 1/2a for surgical innovation in this descriptive study. Results: The first 12 patients were included. All cases were completed without intraoperative complications or conversion. Four patients experienced Clavien–Dindo grade 1 postoperative complications. No patients were re-admitted within 30 days. Median docking time (17 minutes), console time (87.5 minutes), blood loss (40 mL) and length of hospital stay (1 day) were acceptable compared with previous literature. Conclusions: In this pilot study, we found the Medtronic Hugo™ RAS system safe and feasible for robot-assisted surgery for endometriosis. The advent of new robotic systems is welcomed to accelerate the development of technology that will advance surgical care for patients across the globe.
KW - endometriosis
KW - gynecological surgery
KW - Hugo™ RAS
KW - IDEAL framework
KW - robotic surgical procedures
U2 - 10.1111/aogs.14727
DO - 10.1111/aogs.14727
M3 - Journal article
C2 - 38031442
AN - SCOPUS:85178218077
VL - 103
SP - 368
EP - 377
JO - Acta Obstetricia et Gynecologica Scandinavica
JF - Acta Obstetricia et Gynecologica Scandinavica
SN - 0001-6349
IS - 2
ER -
ID: 376457694